172 related articles for article (PubMed ID: 27859253)
1. The many faces of SRPK1.
Bullock N; Oltean S
J Pathol; 2017 Mar; 241(4):437-440. PubMed ID: 27859253
[TBL] [Abstract][Full Text] [Related]
2. Serine-arginine protein kinase 1 promotes a cancer stem cell-like phenotype through activation of Wnt/β-catenin signalling in NSCLC.
Gong L; Song J; Lin X; Wei F; Zhang C; Wang Z; Zhu J; Wu S; Chen Y; Liang J; Fu X; Lu J; Zhou C; Song L
J Pathol; 2016 Oct; 240(2):184-96. PubMed ID: 27391422
[TBL] [Abstract][Full Text] [Related]
3. Serine-Arginine Protein Kinase 1 (SRPK1): a systematic review of its multimodal role in oncogenesis.
Duggan WP; O'Connell E; Prehn JHM; Burke JP
Mol Cell Biochem; 2022 Oct; 477(10):2451-2467. PubMed ID: 35583632
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of SRPK1 in non-small cell lung cancer promotes the growth and migration of cancer cells.
Liu H; Hu X; Zhu Y; Jiang G; Chen S
Tumour Biol; 2016 Jun; 37(6):7287-93. PubMed ID: 26666824
[TBL] [Abstract][Full Text] [Related]
5. Serine-arginine protein kinase 1 (SRPK1) is elevated in gastric cancer and plays oncogenic functions.
Xu X; Wei Y; Wang S; Luo M; Zeng H
Oncotarget; 2017 Sep; 8(37):61944-61957. PubMed ID: 28977917
[TBL] [Abstract][Full Text] [Related]
6. Serine-Arginine Protein Kinase 1 (SRPK1) as a Prognostic Factor and Potential Therapeutic Target in Cancer: Current Evidence and Future Perspectives.
Nikas IP; Themistocleous SC; Paschou SA; Tsamis KI; Ryu HS
Cells; 2019 Dec; 9(1):. PubMed ID: 31861708
[TBL] [Abstract][Full Text] [Related]
7. Serine arginine protein kinase 1 (SRPK1): a moonlighting protein with theranostic ability in cancer prevention.
Patel M; Sachidanandan M; Adnan M
Mol Biol Rep; 2019 Feb; 46(1):1487-1497. PubMed ID: 30535769
[TBL] [Abstract][Full Text] [Related]
8. Identification of hot spot residues on serine-arginine protein kinase-1 by molecular dynamics simulation studies.
Chandra A; Goyal N; Qamar I; Singh N
J Biomol Struct Dyn; 2021 Mar; 39(5):1579-1587. PubMed ID: 32093544
[TBL] [Abstract][Full Text] [Related]
9. Kinome Profiling of Primary Endometrial Tumors Using Multiplexed Inhibitor Beads and Mass Spectrometry Identifies SRPK1 as Candidate Therapeutic Target.
Kurimchak AM; Kumar V; Herrera-Montávez C; Johnson KJ; Srivastava N; Davarajan K; Peri S; Cai KQ; Mantia-Smaldone GM; Duncan JS
Mol Cell Proteomics; 2020 Dec; 19(12):2068-2090. PubMed ID: 32994315
[TBL] [Abstract][Full Text] [Related]
10. Serine-arginine protein kinase 1 overexpression is associated with tumorigenic imbalance in mitogen-activated protein kinase pathways in breast, colonic, and pancreatic carcinomas.
Hayes GM; Carrigan PE; Miller LJ
Cancer Res; 2007 Mar; 67(5):2072-80. PubMed ID: 17332336
[TBL] [Abstract][Full Text] [Related]
11. SRPK1 regulates RNA binding in a pre-spliceosomal complex using a catalytic bypass mechanism.
Aubol BE; Adams JA
FEBS J; 2022 Dec; 289(23):7428-7445. PubMed ID: 35730996
[TBL] [Abstract][Full Text] [Related]
12. Serine-arginine protein kinase 1 (SRPK1) inhibition as a potential novel targeted therapeutic strategy in prostate cancer.
Mavrou A; Brakspear K; Hamdollah-Zadeh M; Damodaran G; Babaei-Jadidi R; Oxley J; Gillatt DA; Ladomery MR; Harper SJ; Bates DO; Oltean S
Oncogene; 2015 Aug; 34(33):4311-9. PubMed ID: 25381816
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of serine/arginine-rich protein kinase-1 (SRPK1) prevents cholangiocarcinoma cells induced angiogenesis.
Supradit K; Boonsri B; Duangdara J; Thitiphatphuvanon T; Suriyonplengsaeng C; Kangsamaksin T; Janvilisri T; Tohtong R; Yacqub-Usman K; Grabowska AM; Bates DO; Wongprasert K
Toxicol In Vitro; 2022 Aug; 82():105385. PubMed ID: 35568131
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel and potent small molecule inhibitor of SRPK1: mechanism of dual inhibition of SRPK1 for the inhibition of cancer progression.
Chandra A; Ananda H; Singh N; Qamar I
Aging (Albany NY); 2020 Dec; 13(1):163-180. PubMed ID: 33291073
[TBL] [Abstract][Full Text] [Related]
15. Serine-arginine protein kinase 1 is associated with breast cancer progression and poor patient survival.
Li XH; Song JW; Liu JL; Wu S; Wang LS; Gong LY; Lin X
Med Oncol; 2014 Aug; 31(8):83. PubMed ID: 24961466
[TBL] [Abstract][Full Text] [Related]
16. The influence of SRPK1 on glioma apoptosis, metastasis, and angiogenesis through the PI3K/Akt signaling pathway under normoxia.
Chang Y; Wu Q; Tian T; Li L; Guo X; Feng Z; Zhou J; Zhang L; Zhou S; Feng G; Han F; Yang J; Huang F
Tumour Biol; 2015 Aug; 36(8):6083-93. PubMed ID: 25833691
[TBL] [Abstract][Full Text] [Related]
17. Expression of SRPK1 in gliomas and its role in glioma cell lines viability.
Sigala I; Tsamis KI; Gousia A; Alexiou G; Voulgaris S; Giannakouros T; Kyritsis AP; Nikolakaki E
Tumour Biol; 2016 Jul; 37(7):8699-707. PubMed ID: 26738865
[TBL] [Abstract][Full Text] [Related]
18. Tumor cell migration screen identifies SRPK1 as breast cancer metastasis determinant.
van Roosmalen W; Le Dévédec SE; Golani O; Smid M; Pulyakhina I; Timmermans AM; Look MP; Zi D; Pont C; de Graauw M; Naffar-Abu-Amara S; Kirsanova C; Rustici G; Hoen PA; Martens JW; Foekens JA; Geiger B; van de Water B
J Clin Invest; 2015 Apr; 125(4):1648-64. PubMed ID: 25774502
[TBL] [Abstract][Full Text] [Related]
19. SRPK1 and Clk/Sty protein kinases show distinct substrate specificities for serine/arginine-rich splicing factors.
Colwill K; Feng LL; Yeakley JM; Gish GD; Cáceres JF; Pawson T; Fu XD
J Biol Chem; 1996 Oct; 271(40):24569-75. PubMed ID: 8798720
[TBL] [Abstract][Full Text] [Related]
20. Elevated SRPK1 lessens apoptosis in breast cancer cells through RBM4-regulated splicing events.
Lin JC; Lin CY; Tarn WY; Li FY
RNA; 2014 Oct; 20(10):1621-31. PubMed ID: 25140042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
